Simplexa HSV 1&2 Direct/Positive Control Pack

FDA 510(k) K141458 · Focus Diagnostics

Substantially Equivalent

510(k) numberK141458

Submission

Device name
Simplexa HSV 1&2 Direct/Positive Control Pack
Applicant
Focus Diagnostics
Cypress, CA, US
Received
June 2, 2014
Decision date
July 1, 2014
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PGH – Hsv-1 And Hsv-2 Cns Nucleic-Acid Based Panel
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3307
Specialty
Microbiology
Life-sustaining
Yes

Intended for the qualitative detection and differentiation of HSV-1 and HSV-2 in cerebrospinal fluid (CSF) from patients with signs and symptoms of Herpes Simplex Virus (HSV) central nervous system (CNS) infection. This test is an aid in the diagnosis of HSV-1 and HSV-2 CNS infections in conjunction with other clinical and laboratory findings. Negative results do not preclude HSV-1 or HSV-2…

Other 510(k)s with product code PGH

510(k)DeviceApplicantDecision
K250050miDiagnostics HSV-1&2 CSF TestPGH · Traditional Midiagnostics NV09/30/2025SE

More from Midiagnostics NV

510(k)DeviceDecision
K152408Simplexa Flu A/B & RSV Direct and Simplexa Flu A/B & RSV Positive Control PackOCC · Special 09/21/2015SE
K150962Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control PackOQO · Traditional 08/28/2015SE
K143651Simplexa Group A Strep Direct, Simplexa Group A Strep Positive Control PackPGX · Traditional 03/18/2015SE
K142365Simplexa Flu A/B & RSV Direct & Simplexa Flu A/B RSV Positive Control PackOCC · Traditional 12/05/2014SE
K120986Stratify JCV DxselectOYP · Traditional 08/16/2012SE
K120413Simplexa Flu A/B & RSV Direct, Simplexa Flu A/B & RSV Positive Control PackOCC · Traditional 07/13/2012SE
K113433Simplexa C. Difficile Universal DirectOMN · Traditional 04/04/2012SE
K102170Simplexa Flu A/B & RSVOCC · Traditional 11/24/2010SE
K1023143M Integrated Cycler (110V) & (220V)OOI · Traditional 10/29/2010SE
K100148Simplexa Influenza a H1N1 (2009) Model MOL2500OQW · Traditional 05/24/2010SE

Questions and answers

When was Simplexa HSV 1&2 Direct/Positive Control Pack cleared by the FDA?

Simplexa HSV 1&2 Direct/Positive Control Pack (K141458) received a 510(k) decision of Substantially Equivalent on July 1, 2014, 29 days after the submission was received.

What is the product code of K141458?

The FDA product code is PGH – Hsv-1 And Hsv-2 Cns Nucleic-Acid Based Panel, a Class II (moderate risk) device regulated under 21 CFR 866.3307.